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ABSTRACT.  The effect of a 20-min exposure to antibody–quantum dot (Ab–QD) conjugates on colony 
counts of Escherichia coli was assessed by the spread-plate method and compared with exposure to unconju-
gated QDs having only amine or carboxyl groups on their surfaces. Under these conditions, Ab–QD conju-
gates generally exhibited > 90 % reduction in colony-forming units as compared to untreated E. coli and E. coli 
treated with unconjugated QDs after incubation for as long as 41 h. The antibacterial effect of Ab–QD 
conjugates vs. unconjugated QDs on Salmonella enterica subsp. enterica serovar Typhimurium was also 
assessed by means of a disk-diffusion technique which demonstrated greater growth inhibition (? 3 mm greater) 
by Ab–QD conjugate-impregnated disks than by unconjugated-QD-only-impregnated disks at a 10-?g disk 
load. At a 25-?g disk load, both treatment groups exhibited nearly equal growth inhibition. 
Abbreviations 
Salmonella Typhimurium Salmonella enterica subsp. enterica serovar Typhimurium 
Ab antibody AMP adenosine monophosphate 
Ab–QD antibody–quantum dot (conjugate) CFU colony-forming unit 
AG Adirondack Green (QD) PBS phosphate-buffered saline  
FO Fort Orange (QD) TSA Tryptic soy agar 
IgM immunoglobulin M TSB trypticase soy broth 
QD quantum dot  
pb p between groups pw p within groups 
Several investigators have reported cytotoxic and antimicrobial effects of fluorescent nanoparticles 
or “quantum dots” (QDs) composed of toxic transition metals such as cadmium and selenium, which appear 
to be dependent on the composition, coating and size of QDs (Shiohara et al. 2004; Hardman 2006) and the 
environmental conditions under which experiments are conducted, including exposure to light (Bakalova et 
al. 2004; Kloepfer et al. 2005). However, exposure to light does not appear to be necessary to induce QD-me-
diated toxicity in all systems (Gurr et al. 2005). Kloepfer et al. (2005) have shown that bacteria cannot 
internalize intact QDs > 5 nm in diameter. However, their data support bacteriostatic effects of QDs as well 
as breakdown and absorption of metal ions from the QDs possibly via oxidative damage to the cell wall, espe-
cially in the presence of light.  
Here we determine the effect of targeting QDs to the bacterial surface via antibody-conjugated QDs 
as assessed by simple colony counts of spread plates and a disk-diffusion method similar to the classic 
Kirby–Bauer test.   
MATERIALS  AND  METHODS 
Antibodies and conjugation to QDs. A monoclonal anti-E. coli O111 IgM was obtained from Novus 
Biologicals (USA); a polyclonal rabbit anti-Salmonella Typhimurium antiserum was developed and tested at 
the University of Bangalore, India. Each antibody was separately conjugated to either amine- or carboxyl-
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derivatized Adirondack GreenTM or Fort OrangeTM QDs (EvidotsTM manufactured in 2003 with the original 
coat formulation by Evident Technologies, USA). Ab–QD conjugates were produced and purified according 
to the manufacturer’s instructions (Dwarakanath et al. 2004).  
Spread-plate method for antibacterial assessment. Single-cell stock suspensions of live E. coli 
O111:B4 were made from TSA cultures in PBS (pH 7.2). The bacterial concentration of experiments 1 and 2 
(Table I) was ?32/nL (i.e. 2 × 106 CFU per mL). For experiments 1 and 2, the stock E. coli suspension was 
diluted sequentially over a range of 104–107-fold in PBS and 50 ?L of the diluted bacterial suspensions were  
 
Table I. Colony counts from various QD and Ab-QD conjugate treatments of E. colia 
Treatment/conditions Dilution Control Ab–amine-QD Ab–carboxyl-QD 
E xp e r i m e n t  1A b
17 h, 50 ?L of Ab–AG QD conjugate 10–4 138 1   1 
 10–5     6 0   0 
 10–6     1 0   0 
 10–7     0 0   0 
E xp e r i m e n t  1B c
Re-incubation 41 h, 50 ?L of Ab–AG QD conjugate 10–4 >300 2 12 
 10–5 >  39 0   2 
 10–6 >    6 0   2 
 10–7     0 0   0 
 
E xp e r i m e n t  2 d
Treatment/conditions Control Volume?L 
Ab  
only Amine-QD Carboxyl-QD 
Ab–carb- 
oxyl-QD 
Varied concentration of unconjugated AG QDs  
    and Ab–AG QD, 16 h 
232   50 242 195 154 10 
Varied concentration of unconjugated AG QDs and h 201 100 231 132   15   2 
Varied concentration of unconjugated AG QDs and  219 200 211   69     2   0 
 
E xp e r i m e n t  3 e
Treatment/conditions QD  type 
Amine- 
QD 
Ab–amine- 
QD 
Carboxyl- 
QD 
Ab–carb- 
oxyl-QD 
Increased bacterial concentration and varied type  
    of QDs, 16 h 
AG >300 48 >300 31 
 FO >250 25 >300 20 
 FO >275 48 >300 37 
aVolumes added are for pure QDs, Ab (monoclonal ascites), or Ab–QDs; two-factor ANOVA performed at ? = 0.05; for further  
  details see text. 
bpb = 0.438, pw = 0.380 . cpb = 0.406, pw = 0.310 . dpb = 9.86 × 10–3, pw = 1.70 × 10–3 . 
eControl >300; volume 200 ?L; pb = 1.36 × 10–9, pw = 0.096.  
 
added to various treatment groups with various amounts of stock (0.25 mg/mL) amine-QDs, carboxyl-QDs, 
or anti-E. coli Ab–QD conjugates (coated with a ? 20 ?g/mL of IgM) (Table I). The contents of each treat-
ment group (e.g., pure QDs or Ab–QD conjugates plus bacteria) were allowed to interact for 20 min at room 
temperature with gentle mixing. TSA spread plates were made from the total contents of each tube and incu-
bated at 35 °C for 17–41 h (Table I). For experiment 3, the stock E. coli suspension concentration was 
increased to 4/nL CFU, which was then diluted 104-fold in PBS and 50 ?L of the diluted stock was used.   
Disk-diffusion method for antibacterial assessement. A Salmonella Typhimurium stock culture was 
inoculated into 50 mL of trypticase soy broth (TSB) and incubated at 37 °C until the absorbance A600 
reached 2.0. Twenty-five-?L aliquots of this culture were uniformly spread on TSA plates; they were left to 
dry for 15 min under a laminar flow hood. Sterile paper discs (diameter 6 mm) were coated with 10 μL of 
different amounts (5, 10, and 25 μg) of Ab–FO QD conjugate. Sterile PBS, various concentrations of uncon-
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jugated FO QDs, and Salmonella Typhimurium antiserum alone were used as controls and also added in 10 ?L 
volumes to sterile paper disks. Once disks were laid onto TSA plates, the plates were incubated at 37 °C for 
2 d and the diameters of inhibitory zones were measured. All tests were done in duplicate and mean values 
of growth inhibition for each treatment are reported. 
RESULTS  AND  DISCUSSION 
The first spread-plate experiment (Table I, experiment 1A) enabled determination of the optimum 
E. coli bacterial dilution (i.e. 10–4) for further experiments and demonstrated that as little as 50 ?L of Ab–
QD conjugate had a strong antibacterial effect after 17 h of incubation. The first experiment was followed by 
re-incubating the spread plates for a total of 41 h (experiment 1B); while the number of CFU in the unexpo-
sed control groups increased > 2× from 138 to almost 300 CFU with additional incubation time, the numbers 
of colonies in the Ab–QD-treated groups remained highly suppressed. These results appear consistent with 
those reported by Kloepfer et al. (2005) in which AMP-conjugated QDs were shown to suppress the replica-
tion of Bacillus subtilis.   
Further examples of how Ab–QD conjugates suppressed E. coli replication vs. much higher concen-
trations of pure amine-coated or carboxyl-coated QDs are shown in experiments 2 and 3 (Table I) wherein 
attachment of antibody to the QD surface appears to greatly suppress colony counts, regardless of the con-
jugation chemistry (i.e., amine- or carboxyl-based). It is noteworthy that the pure QD-treated groups were 
lightly, but visibly, colored, because the QD concentrations were relatively high (50–200 ?g/mL), while the 
Ab–QD-treated groups appeared clear or translucent due to much lower levels of IgM–QDs (?4–16 ?g/mL), 
and yet the Ab–QDs appear significantly more toxic.   
The data in Table I were subjected to a series of two-factor analysis of variance (ANOVA) tests 
without replication (? = 0.05) using Microsoft EXCEL software and found that some of the p values for 
experiments 2 and 3 were highly significant (p < 0.001). Unlike experiments 1A and 1B, the two latter expe-
riments employed only one bacterial dilution (10–4) so that the ANOVA shows a highly significant difference 
between the untreated control, QD-treated, and Ab–QD-treated groups. This is evident from the p values 
displayed for experiments 2 and 3 ( pb < 0.01 in both cases). No significant difference was noted within the 
treatment groups whether AG or FO QDs with or without antibody attachment were employed with the bac-
teria in experiment 3 ( pb > 0.05). This lack of a significant difference within the groups is probably because 
the AG and FO QDs are composed of the same materials (Cd/Se and Zn/S) and only differ in size. There-
fore, their toxicity, whether conjugated to antibodies or not, might be expected to be similar. However, the  
p value between groups in experiment 3 was highly significant, further suggesting that Ab–QD conjugates 
are much more toxic than their unconjugated QD counterparts. 
Similar results were obtained by the disk-diffusion method in that the anti-Salmonella Typhimu-
rium Ab–QD FO conjugate group first showed evidence of a zone of inhibition at 10 ?g of applied con-
jugate, while the unconjugated FO QDs showed no inhibition at 10 ?g of QDs (Table II). At 25 ?g of applied 
conjugate or unconjugated QDs, both treatment groups demonstrated about equal diameters of inhibition 
zone (? 6–7 mm), although the Ab–QD-treated group appeared to hold a slight advantage in diameter of the 
inhibitory zone. The antibacterial enhancement 
by Ab–QDs vs. pure QDs seen in agar by the 
disk-diffusion method is noteworthy, but not as 
dramatic as that seen with the colony-count me-
thod. This may be due to several factors inclu-
ding the species of bacteria used (i.e., E. coli vs. 
Salmonella Typhimurium), differences in anti-
body affinity for their specific target bacteria, 
hampered diffusion (retention) of the Ab–QD con-
jugate or QDs by the paper disks, and potential 
interference of antibody binding to the agar me-
dium.  
The possibility that the polyclonal anti-
sera (ascites fluid) for either E. coli or Salmonel-
la Typhimurium might contain significant levels 
of complement proteins, thereby leading to enhan-
ced cell death, was also considered. In an expe-
riment with 50–200 ?L of pure anti-E. coli IgM 
Table II.  Effect of Ab–FO QD-conjugate and unconjugated-
FO QDs treatmenta on growth (average diameter of  inhibitory 
zone in mm) of Salmonella Typhimurium as assessed by the 
disk-diffusion method 
Amount of QD  
or Ab–QD  
conjugate, ?g 
Incubation
h 
Ab–QD  
conjugate 
Unconjugated 
QD 
10 16 
32 
48 
72 
2.5 
3.0 
3.5 
3.5 
0 
0 
0 
0 
25 16 
32 
48 
72 
6.0 
6.5 
6.5 
7.0 
6.0 
6.0 
6.0 
6.0 
aAt 5 ?g no inhibition was observed for both. 
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ascites fluid added to the bacterial suspension no suppression of colony counts was observed (Table I, 
experiment 2), thus ruling out complement activation as a killing mechanism. It can be therefore concluded 
that antibody conjugation to QDs may enhance their bacterial toxicity.   
The enhanced killing effect may be due to free-radical or oxidative damage to the bacterial cell wall 
and membranes (Kloepfer et al. 2003, 2005) caused by bringing the QDs in close proximity to the bacterial 
surface via antibody binding. We reported fluorescence spectral changes when Ab–QD and DNA aptamer–
QD conjugates bound bacteria (Dwarakanath et al. 2004). Kloepfer et al. (2005) interpreted our fluorescence 
spectral changes as evidence in support of  “energy or electron transfer” from the QDs to the bacterial sur-
face which might be consistent with a free radical or redox toxicity model. Others have reported oxidative 
damage from QDs toward various types of cells in the presence (Bakalova et al. 2004; Hardman 2006; Shi et 
al. 2006) and absence of light (Gurr et al. 2005).   
Kloepfer et al. (2003) also observed bacterial uptake of selenium, but not whole QDs, only when 
the QDs were labeled with holotransferrin (protein) for which the target bacteria had surface receptors. There-
fore, it seems plausible that Ab–QD conjugates might lead to enhanced metal ion uptake, if the QD shell or 
coating is damaged. This potential mechanism may, at least partially, account for the enhanced antibacterial 
action of Ab–QD conjugates vs. pure QDs. The enhanced killing phenomenon should be investigated further, 
because Ab-targeted QD conjugates may have a therapeutic potential as antimicrobial and anticancer agents.   
This work was funded in part by US Army contract no. DACA42-03-C-0063. 
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